Fulton Breakefield Broenniman LLC grew its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 14.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 971 shares of the semiconductor company’s stock after purchasing an additional 126 shares during the quarter. Fulton Breakefield Broenniman LLC’s holdings in Synopsys were worth $471,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of SNPS. Pacifica Partners Inc. bought a new position in shares of Synopsys during the 3rd quarter worth approximately $25,000. Kieckhefer Group LLC bought a new position in Synopsys during the fourth quarter worth $27,000. Tsfg LLC lifted its holdings in shares of Synopsys by 75.0% during the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after buying an additional 24 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in shares of Synopsys by 40.0% during the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after buying an additional 20 shares in the last quarter. Finally, Princeton Global Asset Management LLC acquired a new stake in shares of Synopsys during the third quarter worth $44,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Trading Up 3.0 %
NASDAQ SNPS opened at $526.12 on Wednesday. The firm has a market capitalization of $81.33 billion, a P/E ratio of 36.23, a PEG ratio of 3.57 and a beta of 1.12. The business has a fifty day simple moving average of $518.41 and a 200 day simple moving average of $522.22. Synopsys, Inc. has a 12 month low of $457.52 and a 12 month high of $629.38.
Analyst Ratings Changes
View Our Latest Report on Synopsys
Insider Activity at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the transaction, the executive now owns 1,460 shares in the company, valued at approximately $738,774.60. This represents a 93.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.66% of the stock is currently owned by insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- How Technical Indicators Can Help You Find Oversold Stocks
- 3 Stocks to Gain From Trump’s Family Caregiver Tax Credits
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Charging Forward: 2 US Battery Stocks to Electrify Your Portfolio
- 3 Best Fintech Stocks for a Portfolio Boost
- How Trump’s AI Push Could Boost These 3 Agriculture Stocks
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.